Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Secoisolariciresinol diglycoside has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Deglycosylation, demethylation and dehydroxylation are all bacterial steps performed in the colon. Individuals with the same intake differ several-fold in enterolactone output, and antibiotic exposure collapses production, which is direct evidence the step is microbial. A probiotic does not reliably raise conversion because the responsible taxa are not fully identified. What holds is the dependence itself.
Freeing secoisolariciresinol from its two attached glucose units requires bacterial beta-glucosidase, an activity well described in Bifidobacterium species. The later demethylation and dehydroxylation steps involve different organisms, so no single strain completes the sequence. Adding one strain addresses one step of several.
Enterolignan formation happens where bacterial density and fermentative activity are highest. Fructooligosaccharides are established substrate for that community. The step from more substrate to more enterolactone is inference rather than measurement. It is a defensible formulation choice with no human confirmation for this specific pairing.
Flaxseed supplies alpha-linolenic acid, which converts to EPA at a low and variable rate in humans, and to DHA at lower rates still. Marine oil supplies EPA and DHA directly and bypasses that conversion. The lignan fraction is a separate constituent that survives oil pressing into the meal. Pairing them covers two different things from the same seed's reputation.
Fermentation of resistant starch lowers colonic pH and raises short chain fatty acid production, both of which shape which bacteria are active. Whether that shift favours the enterolignan-producing taxa specifically has not been shown. Read this as mechanistically plausible rather than demonstrated.
Enterolignans are glucuronidated in the liver, secreted in bile and partly deconjugated by bacterial beta-glucuronidase before reabsorption. Calcium D-glucarate is used specifically to inhibit that bacterial glucuronidase. Inhibiting it would be expected to reduce enterolignan reabsorption and shorten their circulation. Whether that happens at supplement doses has not been measured, but the direction is the interesting part.
Nothing specific on file for Secoisolariciresinol diglycoside. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 6 we read for Secoisolariciresinol diglycoside. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.